+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines



Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines



Japanese Journal of Infectious Diseases 58(4): 195-207



Mice recovered from influenza A virus infection have been shown to be cross-protected against challenge infection with either drift viruses within a subtype (subtype-specific immunity) or different subtype viruses (heterosubtypic immunity).

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 012294162

Download citation: RISBibTeXText

PMID: 16116250


Related references

Protection against experimental infection with influenza virus A/equine/Miami/63 (H3N8) provided by inactivated whole virus vaccines containing homologous virus. Epidemiology and Infection 100(3): 501-510, 1988

Mechanisms of Cross-protection by Influenza Virus M2-based Vaccines. Immune Network 15(5): 213-221, 2015

A broad protection provided by matrix protein 2 (M2) of avian influenza virus. Vaccine 33(31): 3758-3765, 2015

Broad cross-protection against H5N1 avian influenza virus infection by means of monoclonal antibodies that map to conserved viral epitopes. Journal of Infectious Diseases 199(1): 49-58, 2009

Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice. Mbio 6(2): E02556, 2015

Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge. Vaccine 27(4): 530-541, 2009

Cross-protection against influenza B type virus infection by intranasal inoculation of the HA vaccines combined with cholera toxin B subunit. Vaccine 8(6): 595-599, 1990

Universal Influenza Vaccines: Progress in Achieving Broad Cross-Protection In Vivo. American Journal of Epidemiology 187(12): 2603-2614, 2018

Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit. Journal of Immunology 149(3): 981-988, 1992

Different cross protection scopes of two avian influenza H5N1 vaccines against infection of layer chickens with a heterologous highly pathogenic virus. Research in Veterinary Science 114: 143-152, 2017

Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets. Plos Medicine 3(9): E360, 2006

Nonreplicating influenza A virus vaccines confer broad protection against lethal challenge. Mbio 6(5): E01487-15, 2015

Live Victoria/75-ts-1[E] influenza A virus vaccines in adult volunteers: role of hemagglutinin immunity in protection against illness and infection caused by influenza A virus. Infection and Immunity 26(1): 274-279, 1979

Impacts on influenza A(H1N1)pdm09 infection from cross-protection of seasonal trivalent influenza vaccines and A(H1N1)pdm09 vaccines: systematic review and meta-analyses. Vaccine 30(21): 3209-3222, 2012

Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice. European Journal of Immunology 10(5): 396-401, 1980